| Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program | Nature | 2021 | 268 |
| Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance | Lancet Infectious Diseases, The | 2021 | 242 |
| SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines | Cell Host and Microbe | 2021 | 225 |
| Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial | BMJ, The | 2021 | 186 |
| Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2021 | 157 |
| Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial | Lancet, The | 2021 | 150 |
| Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination | JAMA Cardiology | 2021 | 115 |
| CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018 | Neuro-Oncology | 2021 | 106 |
| Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis | Nature Medicine | 2021 | 98 |
| Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer | Journal of Clinical Oncology | 2021 | 94 |
| In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies | Cell | 2021 | 89 |
| Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates | Science | 2021 | 86 |
| Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses | Nature | 2021 | 85 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial | Science | 2021 | 84 |
| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Nature Communications | 2021 | 83 |
| Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes | New England Journal of Medicine | 2021 | 79 |
| Telemedicine for the treatment of foot ulcers in people with diabetes | The Cochrane Library | 2021 | 78 |
| Pediatric Giant Prolactinoma Presenting With Acute Obstructive Hydrocephalus and Intracranial Hypertension | Journal of the Endocrine Society | 2021 | 78 |
| The Development of Hypogonadotropic Hypogonadism After Starting Low Dose Mifepristone for Cushing’s Syndrome | Journal of the Endocrine Society | 2021 | 78 |
| OTME-16. Polio virotherapy of murine brain tumors causes microglia/macrophage proliferation and inflammation that is potentiated by immune checkpoint blockade | Neuro-Oncology Advances | 2021 | 78 |
| QS2: Aberrant Breast Adipose Stromal Cell Biology In Women At High Risk For Developing Breast Cancer | Plastic and Reconstructive Surgery - Global Open | 2021 | 78 |
| SURG-07. Plasmonic gold nanostars to increase the efficiency and specificity of laser interstitial thermal therapy (LITT) in the treatment of brain tumors | Neuro-Oncology Advances | 2021 | 78 |
| RADI-09. Clinical factors associated with death after radiotherapy for brain metastases | Neuro-Oncology Advances | 2021 | 78 |
| Optimization of T-Cell Suppression Potency Assay for Human Cord Tissue Mesenchymal Stromal Cells | Stem Cells Translational Medicine | 2021 | 78 |
| CLRM-09. INCORPORATING EXTERNAL CONTROL ARM IN MDNA55 RECURRENT GLIOBLASTOMA REGISTRATION TRIAL | Neuro-Oncology Advances | 2021 | 78 |
